Cargando…

The Cardiovascular Risks of Fostamatinib in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

Objective: This systematic review and meta-analysis is aimed at assessing the risks of cardiovascular adverse events in patients with rheumatoid arthritis (RA) who have been treated with fostamatinib. Methods: The electronic databases of OVID Medline, OVID EMBASE, Cochrane Central Register of Contro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yuehong, Liu, Huan, Huang, Yupeng, Lin, Sang, Yin, Geng, Xie, Qibing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327174/ https://www.ncbi.nlm.nih.gov/pubmed/34349639 http://dx.doi.org/10.3389/fphar.2021.632551

Ejemplares similares

Neoplasm Risk in Patients With Rheumatoid Arthritis Treated With Fostamatinib: A Systematic Review and Meta-analysis
por: Chen, Yuehong, et al.
Publicado: (2022)

Efficacy and Safety of Multiple Dosages of Fostamatinib in Adult Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Kang, Yaqi, et al.
Publicado: (2019)

Epidemiology, methodological quality, and reporting characteristics of systematic reviews and meta-analyses on coronavirus disease 2019: A cross-sectional study
por: Chen, Yuehong, et al.
Publicado: (2021)

Impact of tumor necrosis factor α inhibitors on MRI inflammation in axial spondyloarthritis assessed by Spondyloarthritis Research Consortium Canada score: A meta-analysis
por: Huang, Yupeng, et al.
Publicado: (2020)

Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: systematic review and network meta-analysis
por: Wei, Qige, et al.
Publicado: (2023)

Higher Risk of Cardiovascular Diseases in Rheumatoid Arthritis Patients Without Methotrexate Treatment
por: Hloch, Karel, et al.
Publicado: (2021)

Clinical value of YKL‐40 in patients with polymyositis/dermatomyositis: A cross‐sectional study and a systematic review
por: Cui, Beibei, et al.
Publicado: (2022)

Cinacalcet Targets the Neurokinin-1 Receptor and Inhibits PKCδ/ERK/P65 Signaling to Alleviate Dextran Sulfate Sodium-Induced Colitis
por: Chen, Yuehong, et al.
Publicado: (2021)

The Effectiveness and Safety of Tripterygium wilfordii Hook. F Extracts in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Zhou, Ying-Yan, et al.
Publicado: (2018)

Immunomodulatory Effects of Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Rheumatoid Arthritis
por: Liu, Huan, et al.
Publicado: (2020)

Real-world effectiveness of biological therapy in patients with rheumatoid arthritis: Systematic review and meta-analysis
por: de Castro, Caroline Tianeze, et al.
Publicado: (2022)

Combination effects of herbal and western medicines on osteoporosis in rheumatoid arthritis: systematic review and meta-analysis
por: Kwon, Do Young, et al.
Publicado: (2023)

Association between Serum 25-Hydroxyvitamin D Level and Rheumatoid Arthritis
por: Cen, Xiaomin, et al.
Publicado: (2015)

The Effect of Chinese Medicine Compound in the Treatment of Rheumatoid Arthritis on the Level of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibodies: A Systematic Review and Meta-Analysis
por: Tang, Xuan, et al.
Publicado: (2021)

Elevated Serum IGFBP-2 and CTGF Levels Are Associated with Disease Activity in Patients with Dermatomyositis
por: Yang, Min, et al.
Publicado: (2022)

Adjunctive Chinese Herbal Products Therapy Reduces the Risk of Ischemic Stroke Among Patients With Rheumatoid Arthritis
por: Shen, Hsuan-Shu, et al.
Publicado: (2020)

Safety of biological therapy in patients with rheumatoid arthritis in administrative health databases: A systematic review and meta-analysis
por: de Queiroz, Mariana Jorge, et al.
Publicado: (2022)

Effectiveness and Safety of Iguratimod Monotherapy or Combined With Methotrexate in Treating Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Ouyang, Dan, et al.
Publicado: (2022)

The Bone-Protecting Efficiency of Chinese Medicines Compared With Western Medicines in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Comparative Studies
por: Cai, Xiao, et al.
Publicado: (2018)

Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: A systematic review and meta-analysis of cost-utility studies
por: Kumar, S. Sajith, et al.
Publicado: (2022)

Kunxian Capsule for Rheumatoid Arthritis: Inhibition of Inflammatory Network and Reducing Adverse Reactions Through Drug Matching
por: Tang, Yujun, et al.
Publicado: (2020)

Pathogenesis and Function of Interleukin-35 in Rheumatoid Arthritis
por: Xin, Pan Lin, et al.
Publicado: (2021)

Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape
por: Xie, Sisi, et al.
Publicado: (2020)

Antithrombotic Effects of Fostamatinib in Combination with Conventional Antiplatelet Drugs
por: Harbi, Maan H., et al.
Publicado: (2022)

Cardiovascular risk of Janus kinase inhibitors compared with biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis without underlying cardiovascular diseases: a nationwide cohort study
por: Song, Yun-Kyoung, et al.
Publicado: (2023)

Consistency of recommendations for pharmacotherapy of rheumatoid arthritis
por: Hu, Yue, et al.
Publicado: (2022)

Immunomodulatory roles of metalloproteinases in rheumatoid arthritis
por: Bian, Yanqin, et al.
Publicado: (2023)

The Effect and Safety of Iguratimod Combined With Methotrexate on Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Based on a Randomized Controlled Trial
por: Zeng, Liuting, et al.
Publicado: (2022)

Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib
por: Cooper, Nichola, et al.
Publicado: (2021)

Corrigendum: Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape
por: Xie, Sisi, et al.
Publicado: (2020)

Network analysis combined with pharmacological evaluation strategy to reveal the mechanism of Tibetan medicine Wuwei Shexiang pills in treating rheumatoid arthritis
por: He, Qingxiu, et al.
Publicado: (2022)

Tripterygium Ingredients for Pathogenicity Cells in Rheumatoid Arthritis
por: Tang, Yujun, et al.
Publicado: (2020)

Nanomaterials Manipulate Macrophages for Rheumatoid Arthritis Treatment
por: Li, Shuang, et al.
Publicado: (2021)

Prevention of fostamatinib-induced blood pressure elevation by antihypertensive agents
por: Lengel, Dave, et al.
Publicado: (2015)

Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia
por: Boccia, Ralph, et al.
Publicado: (2020)

Newly discovered circRNAs in rheumatoid arthritis, with special emphasis on functional roles in inflammatory immunity
por: Li, Zhenyu, et al.
Publicado: (2022)

Anti-Rheumatoid Arthritic Effects of Paris Saponin VII in Human Rheumatoid Arthritis Fibroblast-Like Synoviocytes and Adjuvant-Induced Arthritis in Rats
por: Meng, Mei, et al.
Publicado: (2021)

Recent Advances in the Use of Exosomes in Sjögren’s Syndrome
por: Huang, Yupeng, et al.
Publicado: (2020)

An Integrative Pharmacology Model for Decoding the Underlying Therapeutic Mechanisms of Ermiao Powder for Rheumatoid Arthritis
por: Wu, Jie, et al.
Publicado: (2022)

Dysfunctions, Molecular Mechanisms, and Therapeutic Strategies of Regulatory T Cells in Rheumatoid Arthritis
por: Li, Xiaoya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2tvlh3lheoothickg5832hopfc